AKR1C3 and myeloid leukemia: Activating polymorphisms of the AKR1C3 gene has been associated with an increased chance of developing childhood myeloid leukaemia [59], and increased expression of AKR1C3 has been observed in a patient with myelodysplastic syndrome who went on to develop AML-M2 [60].